Report
Coverage updates from the AACR meeting
We gather a few takeaways from the American Association for Cancer Research (AACR) annual meeting, as reported by the companies in our coverage. Data for personalized cancer vaccines was under the spotlight with Moderna first randomised data on its personalized mRNA cancer vaccine (mRNA-4157), and
Provider
Bryan Garnier
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Healthcare Team
Other Reports from Bryan Garnier
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.